Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 05/13/22 12:00:00 on US and Canada Markets.
First quarter earnings exceed expectations. Sierra Metals reported first quarter adjusted net income of $5.9 million, or $0.04 per share, compared with $4.7 million, or $0.03 per share, during the prior year period and our estimate of $5.5 million, or $0.03 per share. Adjusted EBITDA amounted ...
China Approval. Avivagen's oxidized carotenoid-based feed additive, OxC-beta, has received approval for use in China. This is a significant accomplishment for Avivagen and should have a positive impact on operating results going forward. China marks the second key market, along with Vietnam, i...
and a whopping 36.3% higher than our estimate of $79.5 million. Eased COVID restrictions. Management noted that the strong quarter was boosted by the easing of COVID restrictions in many regions and as the Covid Omicron variant faded. This allowed retail revenue to increase and event revenue t...
2022-1Q results surpass expectations. Production levels continue to soar as the company executes a robust drilling program. Production was 8,221 boed up 66% and above our 8,000 boed estimate. Realized prices of $97.5 per barrel and $5.18 per thousand cubic feet (mcf) were up sharply from last ...
Cocrystal Reported 1Q22 With Pipeline Updates. Cocrystal reported a 1Q22 loss of $4.2 million or $(0.04) per share. The company reviewed its recent clinical progress, including its ongoing Phase 1 study of CC-42344 in influenza and plans to initiate two Phase 1 studies of CC-45205 in COVID-19....
Onconova Reported 1Q22. Onconova reported a loss of $4.1 million or $(0.20) per share and gave updates to its clinical trial progress. The Phase 1 dose escalation trials for narazaciclib in solid organ tumors continue to treat patients. The trial in China continues to treat its fifth cohort, w...
1Q22 Results. Revenue of $456.5 million was up 5.2% y-o-y and above our $427 million estimate, with the revenue beat due to the pull forward of some business. Adjusted EBITDA margin of 4% continued to be impacted by the phase-in of new awards and pass through content. Adjusted EPS in the quart...
PDS Biotechnology Reported 1Q22. PDS Biotechnology reported a loss of $8.5 million or $(0.32) per share for 1Q22, consistent with our expectations. The company also gave updates on its clinical trials and pipeline products, and has two upcoming poster presentations scheduled to provide clinica...
TORONTO--(BUSINESS WIRE)-- Sierra Metals Inc. (TSX: SMT) (BVL: SMT) (NYSE AMERICAN: SMTS) ("Sierra Metals" or "the Company") today reported revenue of $57.2 million and an adjusted EBITDA of $16.0 million on the throughput of 590,730 tonnes and metal production of 15.9 million copper equivalen...
A Quarter Filled with Records. ISG had an outstanding first quarter, the Company's best start to a year ever. ISG generated record revenues, record profitability, record recurring revenues, and record consultant utilization. A strong start to the year indeed. Drivers. What was behind the recor...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
22.94%Change Percent:
Sage Therapeutics Inc. Company Name:
SAGE Stock Symbol:
NASDAQ Market:
sagerx.com Website: